StockStory.org on MSN
Clover Health’s (NASDAQ:CLOV) Q3 Sales Beat Estimates But Stock Drops 17.5%
Health insurance company Clover Health (NASDAQ:CLOV) announced in Q3 CY2025, with sales up 50.1% year on year to $496.7 ...
StockStory.org on MSN
CLOV Q3 Deep Dive: Membership Growth Overshadows Profitability Amid Utilization Pressures
Health insurance company Clover Health (NASDAQ:CLOV) reported Q3 CY2025 results , with sales up 50.1% year on year to $496.7 ...
Healthcare technology company Clover Health Investments Corp. (NASDAQ:CLOV) is trading lower after reporting second-quarter financial results after market close on Tuesday. CLOV is seeing a decline in ...
Clover Health Investments, Corp. (CLOV) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback